The anti-TNF therapy downregulated the frequency of Th17 cells in these mice, corroborating previous findings in ankylosing spondylitis patients [20]; therefore, downmodulation of IL-17 is a conserved effect of TNF blocking. This evidence concerns the gene TNF and ankylosing spondylitis.